Lunai (LNAI) news

Trading halted: (LNAI) Due to limit-up limit-down trading pause

Trading in the stock of LNAI has been temporarily suspended due to a limit-up limit-down trading pause, a regulatory mechanism designed to prevent excessive volatility and provide market participants with time to reassess positions. The pause was triggered as the stock’s price moved beyond…

OpenAI: Oct release of GPT-6 Sol & GPT-6 Luna assessed as high capability in cybersecurity, biological, chemical domains under preparedness framework

OpenAI has introduced two new models, GPT-6 Sol and GPT-6 Luna, as part of its GPT-6 series, with a focus on cost efficiency and performance in specialized domains such as cybersecurity, biology, and chemistry. These models are positioned as lower-cost alternatives to the higher-tier GPT-6 Astra,…

Light AI - Will not advance toward FDA submission until readiness established

Light AI Inc. (CBOE CA: ALGO / FSE: 0HC / OTCQB: OHCFF) has indicated that it will not pursue a U.S. Food and Drug Administration (FDA) submission for its investigational Software as a Medical Device (SaMD) product, QuickScan™ Strep A, until it has fully established readiness for regulatory review.…

Lunai Bioworks Inc: Anticipates reporting a net loss for the fiscal year ended June 30, 2026 of about $3.2 million

Lunai Bioworks Inc: Files for non timely 10-K with U.S. SEC

Lunai Bioworks Inc. (NASDAQ: LNAI) has continued to face regulatory scrutiny due to its failure to file required financial reports with the U.S. Securities and Exchange Commission (SEC). The company remains non-compliant with Nasdaq Listing Rule 5250(c)(1), which mandates timely submission of all…